Effect of melarsoprol treatment on circulating IL-10 and TNF-α levels in human African trypanosomiasis

Clinical Immunology and Immunopathology

Volumn 83, Issue 2, 1997, Pages 185-189

  Rhind, Shawn G ^a   Sabiston, Brian H ^a   Shek, Pang N ^a   Buguet, Alain ^b   Muanga, Gaston ^c   Stanghellini, André ^d   Dumas, Michel ^e   Radomski, Manny W ^a  

^a DEF AND CIV INST OF ENVIRON MED   (Canada)

^b CENTRE DE RECHERCHES   (France)

^c Department of Neurology ^*  (Congo)

^d Ministry of Health   (Congo)

^e UNIVERSITÉ DE LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MELARSOPROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TRYPANOSOMIASIS;

EID: 0030960508     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4350     Document Type: Article

References (38)

1. Adams J. H., Haller L., Boa F. Y., Doua F., Dago A., Konian K. Human African trypanosomiasis (T. b. gambiense. Neuropathol. Appl. Neurobiol. 12:1986;81-94.
2. Alafiatayo R. A., Crawley B., Oppenheim B. A., Pentreath V. W. Endotoxins and the pathogenesis ofTrypanosomiasis brucei brucei. Parasitology. 107:1993;49-53.
3. Barcinski M. A., Costa-Moreira M. E. Cellular responses of protozoan parasites to host-derived cytokines. Parasitol. Today. 10:1994;352.
4. Bemelmans M. H. A., van Tits L. J. H., Buurman W. A. Tumor necrosis factor: Production, release and clearance. Crit. Rev. Immunol. 16:1996;1-11.
5. Bruce A. J., Boling W., Kindly M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W., Mattson M. P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2:1996;788-795.
6. Buguet A., Burlet S., Auzelle F., Montmayeur A., Jouvet M., Cespuglio R. Dual intervention of NO in experimental African trypanosomiasis. C. R. Acad. Sci. Paris. 319:1996;201-207.
7. Chao C., Hu S., Petersen P. K. Glia, cytokines, and neurotoxicity. Crit. Rev. Neuorobiol. 9:1995;189-205.
8. Daftarian P. M., Kumar A., Kryworuchko M., Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 in monocytes by tumor necrosis factor-α J. Immunol. 157:1996;12-20.
9. de Waal Malefyt R., Bennett B., Fidgor C., De Vries J. E. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
10. Flynn J. N., Sileghem M. The role of the macrophage in induction of immunosuppression inTrypanosoma congolense. Immunology. 74:1991;310-316.
11. Gérard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents leathality in experimental endotoxemia. J. Exp. Med. 177:1993;547-550.
12. Hunter C. A., Jennings F. W., Kennedy P. G. E., Murray M. Astrocyte activation correlates with cytokine production in central nervous system pathology in experimental African trypanosomiasis. Lab. Invest. 67:1992;635-642.
13. Jakobsen P. H., Bate C. A. W., Taverne J., Playfair J. H. L. Malaria: Toxins, cytokines and disease. Parasite Immunol. 17:1995;223-231.
14. Jennings F. W. Future prospects for the chemotheraphy of human trypanosomiasis. 2. Combination chemotheraphy and African trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 84:1990;618-621.
15. F. Kierszenbaum, M. B. Sztein, 1994, Chagas disease (American trypanosomiasis), Parasitic Infections and the Immune System, 53, 80, Academic Press, London.
16. Kongshavin P. A., Ghadirian E. Enhancing and suppressive effects of tumor necrois factor/cahectin on growth of Trypanosoma musculi. Parasite Immunol. 10:1988;581-588.
17. Lucas R., Magez S., De Leys R., Fransen L., Scheerleinck J.-P., Rampelberg M., Sablon E., De Baetselier P. Mapping the lectin-like activity of tumor necrosis factor. Science. 263:1994;814-817.
18. Lusas R., Magez S., Songa B., Darji A., Hamers R., de Baetselier P. A role for TNF during African trypanosomiasis: Involvement in parasite control, immunosuppression and pathology. Res. Immunol. 144:1993;370.
19. Magez S., Lucus R., Darji A., Songa E. B., Hamers R., De Baetselier P. Murine tumor necrosis factor plays a protective role during the phase of the experimental infection with trypanosoma brucei brucei. Parasite Immunol. 15:1993;635-641.
20. J. M. Mansfield, 1990, Immunology of African trypanosomiasis, Modern Parasite Biology, D. J. Wyler, 222, 246, Freeman, New York.
21. Marchant A., Alegre M. L., Hakim A., Piérard G., Marécaux G., Griedman G., De Groote D., Kahn R. J., Vincent J. L., Goldman M. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol. 15:1995;266-273.
22. Moore K. W., O'Garra A., Malefyt R. D., Vieira P., Mosmann T. R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-179.
23. Mwangi S. M., Odimba F., Logan-Henfrey L. The effect ofTrypanosoma brucei brucei. Acta Trop. 59:1995;283-291.
24. Okomo-Assoumou M. C., Daulouede S., Lemesre J.-L., N'Zila-Mouanda A., Vincendeau P. Correlation of high serum levels of tumor necrosis factor-α with disease severity in human african trypanosomiasis. Am. J. Trop. Med. Hyg. 53:1995;539-543.
25. Pentreath V., Alafiatoyo R. A., Crawley B., Doua F., Oppenheim B. A. Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sickness. Parasitology. 112:1996;67-73.
26. Pentreath V. W. Trypanosomiasis and the nervous system: Pathology and immunology. Trans. R. Soc. Trop. Med. Hyg. 89:1995;9-15.
27. Pépin J., Milford F. The treatment of human African trypanosomiasis. Adv. Parasitol. 33:1994;1-47.
28. Peyron F., Burdin N., Ringwald P., Vuillez J. P., Rousset F., Banchereau J. High levels of IL-10 in human malaria. Clin. Exp. Immunol. 95:1994;300-303.
29. Radomski M. W., Buguet A., Bogui P., Doua F., Lonsdorfer A., Tapie P., Dumas M. Disruptions in the secretion of cortisol, prolactin, and certian cytokines in human African trypanosomiasis patients. Bull. Soc. Pathol. Exp. 87:1995;376-379.
30. Reincke M., Heppner C., Petzke F., Allolio B., Arlt W., Mbulamberi D., Siekmann L., Vollmer D., Winkelmann W., Chrousos G. P. Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. Neuroimmunomodulation. 1:1994;14-22.
31. Rothwell N. J., Luheshik G. N. Brain TNF: Damage limitation or damaged reputation? Nature Med. 2:1996;746-747.
32. M. Sileghem, J. N. Flynn, A. Darji, P. De Baetselier, J. Naessens, 1994, African trypanosomiasis, Parasitic Infections and the Immune System, F. Kierszenbaum, 1, 51, Academic Press, London.
33. Sileghem M., Flynn J. N., Logan-Henfrey L., Ellis J. Tumor necrosis factor production by monocytes from cattle infected withTrypanosoma (Duttonella) vivaxTrypanosoma (Nannomonas) congolense. Parasite Immunol. 16:1994;51-54.
34. Stadnyk A. W., Gauldie J. The acute phase response during parasitic infection. Immunoparasitol. Today. 12/7:1991;A7-A12.
35. Titus R. G., Sherry B., Cerami A., The involvement of TNF IL-. 1 and IL-6 in the immune response to protozoan parasites. Immunoparasitol. Today. 12/7:1991;A13-A16.
36. V. Udhayakumar, P. J. Lammie, K. A. Dimock, A. A. Lal, 1995, Role of cytokines in parasitic infections, Human Cytokines: Their Role in Disease Theraphy, B. B. AggerwalR. K. Puri, 477, 491, Blackwell Scientific, Oxford, England.
37. van der Poll T., Lowry S. F. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock. 3:1995;1-10.
38. Wéry M. Drugs used in the treatment of sleeping sickness (human African trypanosomiasis). Int. J. Antimicrob. Agents. 4:1994;227-238.